Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
351
datasets available to search
ShareScore release 0.9.0
Dataset results
351 results for “empagliflozin”
Bioequivalence of Empagliflozin and Metformin Given as a Fixed Dose Combination Compared to Single Tablets
ClinicalTrials.gov study NCT01844531. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Post-authorization Safety Study in Type 2 Diabetic Patients in Saudi Arabia Treated With Empagliflozin to Assess the Incidence of Ketoacidosis, Severe Complications of Urinary Tract Infection, Volume
ClinicalTrials.gov study NCT03764631. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Drug-drug Interaction of Empagliflozin (BI 10773) and Simvastatin
ClinicalTrials.gov study NCT01304329. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Empagliflozin-based Quadruple Therapy vs Basal Insulin-based Therapy
ClinicalTrials.gov study NCT05103306. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Vo
ClinicalTrials.gov study NCT02577315. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function
ClinicalTrials.gov study NCT01111318. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Empagliflozin and Hepatic Glucose Metabolism
ClinicalTrials.gov study NCT03193684. IPD Sharing: NO. Countries: 1. Publications: 0.
Characteristics of Empagliflozin Initiators
ClinicalTrials.gov study NCT03050619. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single Tablets
ClinicalTrials.gov study NCT01672788. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Based on Data From German Sick Funds That Looks at the Costs of Treatment of Type-2 Diabetic Patients With Empagliflozin vs. DPP-4 Inhibitors vs. GLP-1 Receptor Agonists
ClinicalTrials.gov study NCT04295005. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin in ESKD - A Feasibility Study
ClinicalTrials.gov study NCT05687058. IPD Sharing: YES. Countries: 1. Publications: 0.
REGROUP: Renohemodynamic Effects empaGliflozin in vaRiOUs Populations
ClinicalTrials.gov study NCT04243850. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and
ClinicalTrials.gov study NCT03259490. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Using Swedish Registries to Find Out How Many People With Type 2 Diabetes Had Cardiovascular Disease and Started Treatment With Empagliflozin Between 2015 and 2017
ClinicalTrials.gov study NCT04927858. IPD Sharing: YES. Countries: 1. Publications: 0.
To Assess the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes Mellitus Treated With Empagliflozin
ClinicalTrials.gov study NCT05162014. IPD Sharing: NO. Countries: 1. Publications: 0.
Relative Bioavailability of Empagliflozin (BI 10773) (Final Formulation) Compared to Empagliflozin (BI 10773 XX) (Trial Formulation 2) in Healthy Male and Female Volunteers
ClinicalTrials.gov study NCT01242176. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin Compared With the Free Combination of Empagliflozin Tablet and Linagliptin Tablet in Healthy Male and Female Subjects
ClinicalTrials.gov study NCT02758171. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Emp-Activity: Empagliflozin Functional Capacity
ClinicalTrials.gov study NCT05350202. IPD Sharing: YES. Countries: 6. Publications: 0.
Safety and Efficacy of Empagliflozin in Hemodialysis
ClinicalTrials.gov study NCT05786443. IPD Sharing: YES. Countries: 1. Publications: 0.
Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin
ClinicalTrials.gov study NCT06103279. IPD Sharing: Not stated. Countries: 0. Publications: 16.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.